Your browser doesn't support javascript.
loading
Probing the Virtual Proteome to Identify Novel Disease Biomarkers.
Mosley, Jonathan D; Benson, Mark D; Smith, J Gustav; Melander, Olle; Ngo, Debby; Shaffer, Christian M; Ferguson, Jane F; Herzig, Matthew S; McCarty, Catherine A; Chute, Christopher G; Jarvik, Gail P; Gordon, Adam S; Palmer, Melody R; Crosslin, David R; Larson, Eric B; Carrell, David S; Kullo, Iftikhar J; Pacheco, Jennifer A; Peissig, Peggy L; Brilliant, Murray H; Kitchner, Terrie E; Linneman, James G; Namjou, Bahram; Williams, Marc S; Ritchie, Marylyn D; Borthwick, Kenneth M; Kiryluk, Krzysztof; Mentch, Frank D; Sleiman, Patrick M; Karlson, Elizabeth W; Verma, Shefali S; Zhu, Yineng; Vasan, Ramachandran S; Yang, Qiong; Denny, Josh C; Roden, Dan M; Gerszten, Robert E; Wang, Thomas J.
Afiliação
  • Mosley JD; Department of Medicine (J.D.M., C.M.S., J.F.F., J.C.D., T.J.W.), Vanderbilt University Medical Center, Nashville, TN.
  • Benson MD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA (M.D.B.).
  • Smith JG; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (M.D.B., M.S.H., R.E.G.).
  • Melander O; Molecular Epidemiology and Cardiology, Clinical Sciences, Lund University and Skåne University Hospital, Malmö, Sweden (J.G.S., O.M.).
  • Ngo D; Molecular Epidemiology and Cardiology, Clinical Sciences, Lund University and Skåne University Hospital, Malmö, Sweden (J.G.S., O.M.).
  • Shaffer CM; Department of Medicine and the Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Boston (D.N.).
  • Ferguson JF; Department of Medicine (J.D.M., C.M.S., J.F.F., J.C.D., T.J.W.), Vanderbilt University Medical Center, Nashville, TN.
  • Herzig MS; Department of Medicine (J.D.M., C.M.S., J.F.F., J.C.D., T.J.W.), Vanderbilt University Medical Center, Nashville, TN.
  • McCarty CA; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (M.D.B., M.S.H., R.E.G.).
  • Chute CG; University of Minnesota Medical School, Duluth Campus (C.A.M.).
  • Jarvik GP; Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, MD (C.G.C.).
  • Gordon AS; Departments of Medicine (J.P.J., A.S.G., M.R.P., E.B.L.), University of Washington, Seattle.
  • Palmer MR; Departments of Medicine (J.P.J., A.S.G., M.R.P., E.B.L.), University of Washington, Seattle.
  • Crosslin DR; Departments of Medicine (J.P.J., A.S.G., M.R.P., E.B.L.), University of Washington, Seattle.
  • Larson EB; Biomedical Informatics and Medical Education (D.R.C.), University of Washington, Seattle.
  • Carrell DS; Departments of Medicine (J.P.J., A.S.G., M.R.P., E.B.L.), University of Washington, Seattle.
  • Kullo IJ; Kaiser Permanente Washington Health Research Institute, Seattle, WA (E.B.L., D.S.C.).
  • Pacheco JA; Kaiser Permanente Washington Health Research Institute, Seattle, WA (E.B.L., D.S.C.).
  • Peissig PL; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (I.J.K.).
  • Brilliant MH; Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (J.A.P.).
  • Kitchner TE; Biomedical Informatics Research Center (P.L.P., J.G.L.), Marshfield Clinic Research Institute, WI.
  • Linneman JG; Center for Computational and Biomedical Informatics (M.H.B., T.E.K.), Marshfield Clinic Research Institute, WI.
  • Namjou B; Center for Computational and Biomedical Informatics (M.H.B., T.E.K.), Marshfield Clinic Research Institute, WI.
  • Williams MS; Biomedical Informatics Research Center (P.L.P., J.G.L.), Marshfield Clinic Research Institute, WI.
  • Ritchie MD; Cincinnati Children's Hospital Medical Center and University of Cincinnati, OH (B.N.).
  • Borthwick KM; Genomic Medicine Institute (M.S.W.), Geisinger Health System, Danville, PA.
  • Kiryluk K; Departments of Bioinformatics and Genetics (M.D.R.), University of Pennsylvania, Philadelphia.
  • Mentch FD; Biomedical and Translational Informatics (K.M.B.), Geisinger Health System, Danville, PA.
  • Sleiman PM; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY (K.K.).
  • Karlson EW; Center for Applied Genomics, Children's Hospital of Philadelphia, PA (F.D.M., P.M.S.).
  • Verma SS; Center for Applied Genomics, Children's Hospital of Philadelphia, PA (F.D.M., P.M.S.).
  • Zhu Y; Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (E.W.K.).
  • Vasan RS; Perelman School of Medicine, Department of Genetics (S.S.V.), University of Pennsylvania, Philadelphia.
  • Yang Q; Department of Biostatistics, Boston University School of Public Health, MA (Y.Z., Q.Y.).
  • Denny JC; Department of Medicine, Boston University School of Medicine, MA (R.S.V.).
  • Roden DM; Department of Biostatistics, Boston University School of Public Health, MA (Y.Z., Q.Y.).
  • Gerszten RE; Department of Medicine (J.D.M., C.M.S., J.F.F., J.C.D., T.J.W.), Vanderbilt University Medical Center, Nashville, TN.
  • Wang TJ; Biomedical Informatics (J.C.D., D.M.R.), Vanderbilt University Medical Center, Nashville, TN.
Circulation ; 138(22): 2469-2481, 2018 11 27.
Article em En | MEDLINE | ID: mdl-30571344
ABSTRACT

BACKGROUND:

Proteomic approaches allow measurement of thousands of proteins in a single specimen, which can accelerate biomarker discovery. However, applying these technologies to massive biobanks is not currently feasible because of the practical barriers and costs of implementing such assays at scale. To overcome these challenges, we used a "virtual proteomic" approach, linking genetically predicted protein levels to clinical diagnoses in >40 000 individuals.

METHODS:

We used genome-wide association data from the Framingham Heart Study (n=759) to construct genetic predictors for 1129 plasma protein levels. We validated the genetic predictors for 268 proteins and used them to compute predicted protein levels in 41 288 genotyped individuals in the Electronic Medical Records and Genomics (eMERGE) cohort. We tested associations for each predicted protein with 1128 clinical phenotypes. Lead associations were validated with directly measured protein levels and either low-density lipoprotein cholesterol or subclinical atherosclerosis in the MDCS (Malmö Diet and Cancer Study; n=651).

RESULTS:

In the virtual proteomic analysis in eMERGE, 55 proteins were associated with 89 distinct diagnoses at a false discovery rate q<0.1. Among these, 13 associations involved lipid (n=7) or atherosclerosis (n=6) phenotypes. We tested each association for validation in MDCS using directly measured protein levels. At Bonferroni-adjusted significance thresholds, levels of apolipoprotein E isoforms were associated with hyperlipidemia, and circulating C-type lectin domain family 1 member B and platelet-derived growth factor receptor-ß predicted subclinical atherosclerosis. Odds ratios for carotid atherosclerosis were 1.31 (95% CI, 1.08-1.58; P=0.006) per 1-SD increment in C-type lectin domain family 1 member B and 0.79 (0.66-0.94; P=0.008) per 1-SD increment in platelet-derived growth factor receptor-ß.

CONCLUSIONS:

We demonstrate a biomarker discovery paradigm to identify candidate biomarkers of cardiovascular and other diseases.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Doenças das Artérias Carótidas / Proteoma / Estudo de Associação Genômica Ampla Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Doenças das Artérias Carótidas / Proteoma / Estudo de Associação Genômica Ampla Idioma: En Ano de publicação: 2018 Tipo de documento: Article